The Vice-Chairman of the Board and a co-founder the Sartar Therapeutics Professor Heikki Joensuu has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation. Congratulations Heikki on your new appointment!
Sartar was awarded a USA patent for use of anagrelide in cancer therapy.
Sartar Therapeutics participated to the HealthBIO pitching competition and won it.
Sartar will participate in the Next Generation tract company presentations in the BIO-Europe conference at Wednesday 8th of November.
Sartar participates in HealthBIO partnering event.